nodes	percent_of_prediction	percent_of_DWPC	metapath
Rizatriptan—migraine—Prednisone—systemic scleroderma	0.766	1	CpDpCtD
Rizatriptan—CYP1A2—Pentoxifylline—systemic scleroderma	0.0291	0.512	CbGbCtD
Rizatriptan—CYP1A2—Leflunomide—systemic scleroderma	0.0278	0.488	CbGbCtD
Rizatriptan—Osteoarthritis—Methotrexate—systemic scleroderma	0.0002	0.00113	CcSEcCtD
Rizatriptan—Confusional state—Lisinopril—systemic scleroderma	0.000199	0.00112	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000199	0.00112	CcSEcCtD
Rizatriptan—Headache—Mometasone—systemic scleroderma	0.000199	0.00112	CcSEcCtD
Rizatriptan—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000199	0.00112	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000199	0.00112	CcSEcCtD
Rizatriptan—Insomnia—Mycophenolic acid—systemic scleroderma	0.000199	0.00112	CcSEcCtD
Rizatriptan—Fatigue—Leflunomide—systemic scleroderma	0.000198	0.00112	CcSEcCtD
Rizatriptan—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000198	0.00111	CcSEcCtD
Rizatriptan—Oedema—Lisinopril—systemic scleroderma	0.000198	0.00111	CcSEcCtD
Rizatriptan—Pruritus—Captopril—systemic scleroderma	0.000197	0.00111	CcSEcCtD
Rizatriptan—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000197	0.00111	CcSEcCtD
Rizatriptan—Pain—Leflunomide—systemic scleroderma	0.000197	0.00111	CcSEcCtD
Rizatriptan—Constipation—Leflunomide—systemic scleroderma	0.000197	0.00111	CcSEcCtD
Rizatriptan—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000196	0.0011	CcSEcCtD
Rizatriptan—Somnolence—Mycophenolic acid—systemic scleroderma	0.000195	0.0011	CcSEcCtD
Rizatriptan—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000195	0.0011	CcSEcCtD
Rizatriptan—Shock—Lisinopril—systemic scleroderma	0.000194	0.0011	CcSEcCtD
Rizatriptan—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000194	0.00109	CcSEcCtD
Rizatriptan—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000193	0.00109	CcSEcCtD
Rizatriptan—Tachycardia—Lisinopril—systemic scleroderma	0.000193	0.00109	CcSEcCtD
Rizatriptan—Body temperature increased—Azathioprine—systemic scleroderma	0.000193	0.00109	CcSEcCtD
Rizatriptan—Abdominal pain—Azathioprine—systemic scleroderma	0.000193	0.00109	CcSEcCtD
Rizatriptan—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000191	0.00108	CcSEcCtD
Rizatriptan—Diarrhoea—Captopril—systemic scleroderma	0.000191	0.00108	CcSEcCtD
Rizatriptan—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000191	0.00108	CcSEcCtD
Rizatriptan—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000191	0.00107	CcSEcCtD
Rizatriptan—Irritability—Methotrexate—systemic scleroderma	0.000191	0.00107	CcSEcCtD
Rizatriptan—Syncope—Mycophenolate mofetil—systemic scleroderma	0.00019	0.00107	CcSEcCtD
Rizatriptan—Feeling abnormal—Leflunomide—systemic scleroderma	0.00019	0.00107	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000189	0.00107	CcSEcCtD
Rizatriptan—Fatigue—Mycophenolic acid—systemic scleroderma	0.000189	0.00107	CcSEcCtD
Rizatriptan—Nausea—Mometasone—systemic scleroderma	0.000189	0.00106	CcSEcCtD
Rizatriptan—Anorexia—Lisinopril—systemic scleroderma	0.000188	0.00106	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000188	0.00106	CcSEcCtD
Rizatriptan—Ataxia—Methotrexate—systemic scleroderma	0.000188	0.00106	CcSEcCtD
Rizatriptan—Pain—Mycophenolic acid—systemic scleroderma	0.000188	0.00106	CcSEcCtD
Rizatriptan—Constipation—Mycophenolic acid—systemic scleroderma	0.000188	0.00106	CcSEcCtD
Rizatriptan—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000188	0.00106	CcSEcCtD
Rizatriptan—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000187	0.00105	CcSEcCtD
Rizatriptan—Cough—Mycophenolate mofetil—systemic scleroderma	0.000185	0.00104	CcSEcCtD
Rizatriptan—Dizziness—Captopril—systemic scleroderma	0.000185	0.00104	CcSEcCtD
Rizatriptan—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000184	0.00104	CcSEcCtD
Rizatriptan—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000183	0.00103	CcSEcCtD
Rizatriptan—Urticaria—Leflunomide—systemic scleroderma	0.000183	0.00103	CcSEcCtD
Rizatriptan—Abdominal pain—Leflunomide—systemic scleroderma	0.000182	0.00103	CcSEcCtD
Rizatriptan—Body temperature increased—Leflunomide—systemic scleroderma	0.000182	0.00103	CcSEcCtD
Rizatriptan—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000181	0.00102	CcSEcCtD
Rizatriptan—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000181	0.00102	CcSEcCtD
Rizatriptan—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000181	0.00102	CcSEcCtD
Rizatriptan—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000181	0.00102	CcSEcCtD
Rizatriptan—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000181	0.00102	CcSEcCtD
Rizatriptan—Myocardial infarction—Prednisone—systemic scleroderma	0.00018	0.00102	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.00018	0.00102	CcSEcCtD
Rizatriptan—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.00018	0.00101	CcSEcCtD
Rizatriptan—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.00018	0.00101	CcSEcCtD
Rizatriptan—Hypersensitivity—Azathioprine—systemic scleroderma	0.000179	0.00101	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000179	0.00101	CcSEcCtD
Rizatriptan—Insomnia—Lisinopril—systemic scleroderma	0.000179	0.00101	CcSEcCtD
Rizatriptan—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000179	0.00101	CcSEcCtD
Rizatriptan—Paraesthesia—Lisinopril—systemic scleroderma	0.000178	0.001	CcSEcCtD
Rizatriptan—Vomiting—Captopril—systemic scleroderma	0.000177	0.001	CcSEcCtD
Rizatriptan—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000177	0.000996	CcSEcCtD
Rizatriptan—Dyspnoea—Lisinopril—systemic scleroderma	0.000176	0.000994	CcSEcCtD
Rizatriptan—Rash—Captopril—systemic scleroderma	0.000176	0.000992	CcSEcCtD
Rizatriptan—Dermatitis—Captopril—systemic scleroderma	0.000176	0.000991	CcSEcCtD
Rizatriptan—Somnolence—Lisinopril—systemic scleroderma	0.000176	0.000991	CcSEcCtD
Rizatriptan—Headache—Captopril—systemic scleroderma	0.000175	0.000986	CcSEcCtD
Rizatriptan—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000175	0.000984	CcSEcCtD
Rizatriptan—Dyspepsia—Lisinopril—systemic scleroderma	0.000174	0.000981	CcSEcCtD
Rizatriptan—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000174	0.000978	CcSEcCtD
Rizatriptan—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000174	0.000978	CcSEcCtD
Rizatriptan—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000173	0.000976	CcSEcCtD
Rizatriptan—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000173	0.000976	CcSEcCtD
Rizatriptan—Decreased appetite—Lisinopril—systemic scleroderma	0.000172	0.000969	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000171	0.000962	CcSEcCtD
Rizatriptan—Fatigue—Lisinopril—systemic scleroderma	0.00017	0.000961	CcSEcCtD
Rizatriptan—Shock—Mycophenolate mofetil—systemic scleroderma	0.00017	0.000961	CcSEcCtD
Rizatriptan—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.00017	0.000958	CcSEcCtD
Rizatriptan—Hypersensitivity—Leflunomide—systemic scleroderma	0.00017	0.000955	CcSEcCtD
Rizatriptan—Constipation—Lisinopril—systemic scleroderma	0.000169	0.000953	CcSEcCtD
Rizatriptan—Pain—Lisinopril—systemic scleroderma	0.000169	0.000953	CcSEcCtD
Rizatriptan—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000169	0.000953	CcSEcCtD
Rizatriptan—Bradycardia—Prednisone—systemic scleroderma	0.000168	0.000948	CcSEcCtD
Rizatriptan—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000167	0.000944	CcSEcCtD
Rizatriptan—Diarrhoea—Azathioprine—systemic scleroderma	0.000167	0.00094	CcSEcCtD
Rizatriptan—Nausea—Captopril—systemic scleroderma	0.000166	0.000935	CcSEcCtD
Rizatriptan—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000165	0.000932	CcSEcCtD
Rizatriptan—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000165	0.000931	CcSEcCtD
Rizatriptan—Asthenia—Leflunomide—systemic scleroderma	0.000165	0.00093	CcSEcCtD
Rizatriptan—Hallucination—Prednisone—systemic scleroderma	0.000164	0.000927	CcSEcCtD
Rizatriptan—Feeling abnormal—Lisinopril—systemic scleroderma	0.000163	0.000918	CcSEcCtD
Rizatriptan—Pruritus—Leflunomide—systemic scleroderma	0.000163	0.000918	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000162	0.000911	CcSEcCtD
Rizatriptan—Dysuria—Methotrexate—systemic scleroderma	0.000161	0.00091	CcSEcCtD
Rizatriptan—Dizziness—Azathioprine—systemic scleroderma	0.000161	0.000908	CcSEcCtD
Rizatriptan—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.00016	0.000904	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000158	0.00089	CcSEcCtD
Rizatriptan—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000158	0.000888	CcSEcCtD
Rizatriptan—Asthenia—Mycophenolic acid—systemic scleroderma	0.000157	0.000888	CcSEcCtD
Rizatriptan—Diarrhoea—Leflunomide—systemic scleroderma	0.000157	0.000887	CcSEcCtD
Rizatriptan—Urticaria—Lisinopril—systemic scleroderma	0.000157	0.000885	CcSEcCtD
Rizatriptan—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000157	0.000883	CcSEcCtD
Rizatriptan—Abdominal pain—Lisinopril—systemic scleroderma	0.000156	0.000881	CcSEcCtD
Rizatriptan—Body temperature increased—Lisinopril—systemic scleroderma	0.000156	0.000881	CcSEcCtD
Rizatriptan—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000156	0.000877	CcSEcCtD
Rizatriptan—Pruritus—Mycophenolic acid—systemic scleroderma	0.000155	0.000875	CcSEcCtD
Rizatriptan—Vomiting—Azathioprine—systemic scleroderma	0.000155	0.000873	CcSEcCtD
Rizatriptan—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000154	0.00087	CcSEcCtD
Rizatriptan—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000154	0.000868	CcSEcCtD
Rizatriptan—Rash—Azathioprine—systemic scleroderma	0.000154	0.000866	CcSEcCtD
Rizatriptan—Dermatitis—Azathioprine—systemic scleroderma	0.000153	0.000865	CcSEcCtD
Rizatriptan—Flushing—Prednisone—systemic scleroderma	0.000153	0.000865	CcSEcCtD
Rizatriptan—Headache—Azathioprine—systemic scleroderma	0.000153	0.00086	CcSEcCtD
Rizatriptan—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000152	0.000859	CcSEcCtD
Rizatriptan—Dizziness—Leflunomide—systemic scleroderma	0.000152	0.000858	CcSEcCtD
Rizatriptan—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000151	0.000849	CcSEcCtD
Rizatriptan—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00015	0.000847	CcSEcCtD
Rizatriptan—Angiopathy—Prednisone—systemic scleroderma	0.00015	0.000845	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00015	0.000843	CcSEcCtD
Rizatriptan—Pain—Mycophenolate mofetil—systemic scleroderma	0.000148	0.000835	CcSEcCtD
Rizatriptan—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000148	0.000835	CcSEcCtD
Rizatriptan—Arrhythmia—Prednisone—systemic scleroderma	0.000148	0.000832	CcSEcCtD
Rizatriptan—Sweating—Methotrexate—systemic scleroderma	0.000147	0.000831	CcSEcCtD
Rizatriptan—Vomiting—Leflunomide—systemic scleroderma	0.000146	0.000825	CcSEcCtD
Rizatriptan—Hypersensitivity—Lisinopril—systemic scleroderma	0.000146	0.000821	CcSEcCtD
Rizatriptan—Dizziness—Mycophenolic acid—systemic scleroderma	0.000145	0.000818	CcSEcCtD
Rizatriptan—Epistaxis—Methotrexate—systemic scleroderma	0.000145	0.000818	CcSEcCtD
Rizatriptan—Rash—Leflunomide—systemic scleroderma	0.000145	0.000818	CcSEcCtD
Rizatriptan—Dermatitis—Leflunomide—systemic scleroderma	0.000145	0.000817	CcSEcCtD
Rizatriptan—Mental disorder—Prednisone—systemic scleroderma	0.000145	0.000816	CcSEcCtD
Rizatriptan—Nausea—Azathioprine—systemic scleroderma	0.000145	0.000816	CcSEcCtD
Rizatriptan—Headache—Leflunomide—systemic scleroderma	0.000144	0.000812	CcSEcCtD
Rizatriptan—Erythema—Prednisone—systemic scleroderma	0.000144	0.000811	CcSEcCtD
Rizatriptan—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000143	0.000805	CcSEcCtD
Rizatriptan—Asthenia—Lisinopril—systemic scleroderma	0.000142	0.0008	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000142	0.000798	CcSEcCtD
Rizatriptan—Pruritus—Lisinopril—systemic scleroderma	0.00014	0.000788	CcSEcCtD
Rizatriptan—Vomiting—Mycophenolic acid—systemic scleroderma	0.00014	0.000787	CcSEcCtD
Rizatriptan—Rash—Mycophenolic acid—systemic scleroderma	0.000138	0.00078	CcSEcCtD
Rizatriptan—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000138	0.000779	CcSEcCtD
Rizatriptan—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000138	0.000776	CcSEcCtD
Rizatriptan—Headache—Mycophenolic acid—systemic scleroderma	0.000137	0.000775	CcSEcCtD
Rizatriptan—Pharyngitis—Methotrexate—systemic scleroderma	0.000137	0.000773	CcSEcCtD
Rizatriptan—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000137	0.000772	CcSEcCtD
Rizatriptan—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000137	0.000772	CcSEcCtD
Rizatriptan—Nausea—Leflunomide—systemic scleroderma	0.000137	0.00077	CcSEcCtD
Rizatriptan—Vision blurred—Prednisone—systemic scleroderma	0.000136	0.000764	CcSEcCtD
Rizatriptan—Diarrhoea—Lisinopril—systemic scleroderma	0.000135	0.000762	CcSEcCtD
Rizatriptan—Agitation—Prednisone—systemic scleroderma	0.000132	0.000745	CcSEcCtD
Rizatriptan—Angioedema—Prednisone—systemic scleroderma	0.000131	0.000741	CcSEcCtD
Rizatriptan—Dizziness—Lisinopril—systemic scleroderma	0.000131	0.000737	CcSEcCtD
Rizatriptan—Nausea—Mycophenolic acid—systemic scleroderma	0.00013	0.000735	CcSEcCtD
Rizatriptan—Vertigo—Prednisone—systemic scleroderma	0.000129	0.000729	CcSEcCtD
Rizatriptan—Syncope—Prednisone—systemic scleroderma	0.000129	0.000727	CcSEcCtD
Rizatriptan—Tinnitus—Methotrexate—systemic scleroderma	0.000129	0.000726	CcSEcCtD
Rizatriptan—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000128	0.000719	CcSEcCtD
Rizatriptan—Loss of consciousness—Prednisone—systemic scleroderma	0.000126	0.000713	CcSEcCtD
Rizatriptan—Vomiting—Lisinopril—systemic scleroderma	0.000126	0.000709	CcSEcCtD
Rizatriptan—Angiopathy—Methotrexate—systemic scleroderma	0.000125	0.000706	CcSEcCtD
Rizatriptan—Rash—Lisinopril—systemic scleroderma	0.000125	0.000703	CcSEcCtD
Rizatriptan—Convulsion—Prednisone—systemic scleroderma	0.000125	0.000703	CcSEcCtD
Rizatriptan—Dermatitis—Lisinopril—systemic scleroderma	0.000125	0.000702	CcSEcCtD
Rizatriptan—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000124	0.000701	CcSEcCtD
Rizatriptan—Hypertension—Prednisone—systemic scleroderma	0.000124	0.0007	CcSEcCtD
Rizatriptan—Chills—Methotrexate—systemic scleroderma	0.000124	0.000699	CcSEcCtD
Rizatriptan—Headache—Lisinopril—systemic scleroderma	0.000124	0.000698	CcSEcCtD
Rizatriptan—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000123	0.000691	CcSEcCtD
Rizatriptan—Arthralgia—Prednisone—systemic scleroderma	0.000122	0.00069	CcSEcCtD
Rizatriptan—Myalgia—Prednisone—systemic scleroderma	0.000122	0.00069	CcSEcCtD
Rizatriptan—Anxiety—Prednisone—systemic scleroderma	0.000122	0.000688	CcSEcCtD
Rizatriptan—Discomfort—Prednisone—systemic scleroderma	0.000121	0.000682	CcSEcCtD
Rizatriptan—Mental disorder—Methotrexate—systemic scleroderma	0.000121	0.000682	CcSEcCtD
Rizatriptan—Erythema—Methotrexate—systemic scleroderma	0.00012	0.000678	CcSEcCtD
Rizatriptan—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000119	0.000668	CcSEcCtD
Rizatriptan—Dysgeusia—Methotrexate—systemic scleroderma	0.000118	0.000664	CcSEcCtD
Rizatriptan—Nausea—Lisinopril—systemic scleroderma	0.000117	0.000662	CcSEcCtD
Rizatriptan—Anaphylactic shock—Prednisone—systemic scleroderma	0.000117	0.000662	CcSEcCtD
Rizatriptan—Oedema—Prednisone—systemic scleroderma	0.000117	0.000662	CcSEcCtD
Rizatriptan—Shock—Prednisone—systemic scleroderma	0.000116	0.000651	CcSEcCtD
Rizatriptan—Nervous system disorder—Prednisone—systemic scleroderma	0.000115	0.000649	CcSEcCtD
Rizatriptan—Tachycardia—Prednisone—systemic scleroderma	0.000115	0.000646	CcSEcCtD
Rizatriptan—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000115	0.000646	CcSEcCtD
Rizatriptan—Hyperhidrosis—Prednisone—systemic scleroderma	0.000114	0.00064	CcSEcCtD
Rizatriptan—Vision blurred—Methotrexate—systemic scleroderma	0.000113	0.000639	CcSEcCtD
Rizatriptan—Anorexia—Prednisone—systemic scleroderma	0.000112	0.000631	CcSEcCtD
Rizatriptan—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.00011	0.000621	CcSEcCtD
Rizatriptan—Rash—Mycophenolate mofetil—systemic scleroderma	0.000109	0.000616	CcSEcCtD
Rizatriptan—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000109	0.000615	CcSEcCtD
Rizatriptan—Headache—Mycophenolate mofetil—systemic scleroderma	0.000109	0.000612	CcSEcCtD
Rizatriptan—Vertigo—Methotrexate—systemic scleroderma	0.000108	0.000609	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000107	0.000603	CcSEcCtD
Rizatriptan—Insomnia—Prednisone—systemic scleroderma	0.000106	0.000599	CcSEcCtD
Rizatriptan—Paraesthesia—Prednisone—systemic scleroderma	0.000105	0.000594	CcSEcCtD
Rizatriptan—Cough—Methotrexate—systemic scleroderma	0.000105	0.000591	CcSEcCtD
Rizatriptan—Convulsion—Methotrexate—systemic scleroderma	0.000104	0.000587	CcSEcCtD
Rizatriptan—Dyspepsia—Prednisone—systemic scleroderma	0.000103	0.000583	CcSEcCtD
Rizatriptan—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000103	0.00058	CcSEcCtD
Rizatriptan—Arthralgia—Methotrexate—systemic scleroderma	0.000102	0.000577	CcSEcCtD
Rizatriptan—Myalgia—Methotrexate—systemic scleroderma	0.000102	0.000577	CcSEcCtD
Rizatriptan—Chest pain—Methotrexate—systemic scleroderma	0.000102	0.000577	CcSEcCtD
Rizatriptan—Decreased appetite—Prednisone—systemic scleroderma	0.000102	0.000575	CcSEcCtD
Rizatriptan—Fatigue—Prednisone—systemic scleroderma	0.000101	0.000571	CcSEcCtD
Rizatriptan—Discomfort—Methotrexate—systemic scleroderma	0.000101	0.00057	CcSEcCtD
Rizatriptan—Constipation—Prednisone—systemic scleroderma	0.0001	0.000566	CcSEcCtD
Rizatriptan—Confusional state—Methotrexate—systemic scleroderma	9.89e-05	0.000558	CcSEcCtD
Rizatriptan—Anaphylactic shock—Methotrexate—systemic scleroderma	9.81e-05	0.000553	CcSEcCtD
Rizatriptan—Feeling abnormal—Prednisone—systemic scleroderma	9.68e-05	0.000545	CcSEcCtD
Rizatriptan—Nervous system disorder—Methotrexate—systemic scleroderma	9.62e-05	0.000542	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Prednisone—systemic scleroderma	9.6e-05	0.000541	CcSEcCtD
Rizatriptan—Hyperhidrosis—Methotrexate—systemic scleroderma	9.49e-05	0.000535	CcSEcCtD
Rizatriptan—Anorexia—Methotrexate—systemic scleroderma	9.35e-05	0.000527	CcSEcCtD
Rizatriptan—Urticaria—Prednisone—systemic scleroderma	9.33e-05	0.000526	CcSEcCtD
Rizatriptan—Body temperature increased—Prednisone—systemic scleroderma	9.28e-05	0.000523	CcSEcCtD
Rizatriptan—Abdominal pain—Prednisone—systemic scleroderma	9.28e-05	0.000523	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	8.94e-05	0.000504	CcSEcCtD
Rizatriptan—Insomnia—Methotrexate—systemic scleroderma	8.87e-05	0.0005	CcSEcCtD
Rizatriptan—Paraesthesia—Methotrexate—systemic scleroderma	8.81e-05	0.000497	CcSEcCtD
Rizatriptan—Dyspnoea—Methotrexate—systemic scleroderma	8.75e-05	0.000493	CcSEcCtD
Rizatriptan—Somnolence—Methotrexate—systemic scleroderma	8.72e-05	0.000492	CcSEcCtD
Rizatriptan—Hypersensitivity—Prednisone—systemic scleroderma	8.65e-05	0.000488	CcSEcCtD
Rizatriptan—Dyspepsia—Methotrexate—systemic scleroderma	8.64e-05	0.000487	CcSEcCtD
Rizatriptan—Decreased appetite—Methotrexate—systemic scleroderma	8.53e-05	0.000481	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Methotrexate—systemic scleroderma	8.47e-05	0.000478	CcSEcCtD
Rizatriptan—Fatigue—Methotrexate—systemic scleroderma	8.46e-05	0.000477	CcSEcCtD
Rizatriptan—Asthenia—Prednisone—systemic scleroderma	8.42e-05	0.000475	CcSEcCtD
Rizatriptan—Pain—Methotrexate—systemic scleroderma	8.39e-05	0.000473	CcSEcCtD
Rizatriptan—Pruritus—Prednisone—systemic scleroderma	8.31e-05	0.000468	CcSEcCtD
Rizatriptan—Feeling abnormal—Methotrexate—systemic scleroderma	8.09e-05	0.000456	CcSEcCtD
Rizatriptan—Diarrhoea—Prednisone—systemic scleroderma	8.03e-05	0.000453	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Methotrexate—systemic scleroderma	8.02e-05	0.000452	CcSEcCtD
Rizatriptan—Urticaria—Methotrexate—systemic scleroderma	7.8e-05	0.000439	CcSEcCtD
Rizatriptan—Dizziness—Prednisone—systemic scleroderma	7.76e-05	0.000438	CcSEcCtD
Rizatriptan—Abdominal pain—Methotrexate—systemic scleroderma	7.76e-05	0.000437	CcSEcCtD
Rizatriptan—Body temperature increased—Methotrexate—systemic scleroderma	7.76e-05	0.000437	CcSEcCtD
Rizatriptan—Vomiting—Prednisone—systemic scleroderma	7.47e-05	0.000421	CcSEcCtD
Rizatriptan—Rash—Prednisone—systemic scleroderma	7.4e-05	0.000417	CcSEcCtD
Rizatriptan—Dermatitis—Prednisone—systemic scleroderma	7.4e-05	0.000417	CcSEcCtD
Rizatriptan—Headache—Prednisone—systemic scleroderma	7.36e-05	0.000415	CcSEcCtD
Rizatriptan—Hypersensitivity—Methotrexate—systemic scleroderma	7.23e-05	0.000408	CcSEcCtD
Rizatriptan—Asthenia—Methotrexate—systemic scleroderma	7.04e-05	0.000397	CcSEcCtD
Rizatriptan—Nausea—Prednisone—systemic scleroderma	6.97e-05	0.000393	CcSEcCtD
Rizatriptan—Pruritus—Methotrexate—systemic scleroderma	6.94e-05	0.000391	CcSEcCtD
Rizatriptan—Diarrhoea—Methotrexate—systemic scleroderma	6.71e-05	0.000378	CcSEcCtD
Rizatriptan—Dizziness—Methotrexate—systemic scleroderma	6.49e-05	0.000366	CcSEcCtD
Rizatriptan—Vomiting—Methotrexate—systemic scleroderma	6.24e-05	0.000352	CcSEcCtD
Rizatriptan—Rash—Methotrexate—systemic scleroderma	6.19e-05	0.000349	CcSEcCtD
Rizatriptan—Dermatitis—Methotrexate—systemic scleroderma	6.18e-05	0.000348	CcSEcCtD
Rizatriptan—Headache—Methotrexate—systemic scleroderma	6.15e-05	0.000347	CcSEcCtD
Rizatriptan—Nausea—Methotrexate—systemic scleroderma	5.83e-05	0.000329	CcSEcCtD
